Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$782,914
-$275,892 QoQ
Shares Held
10,895
+21.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#694
of 1,408 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Meeder Advisory Services, Inc. holds $2,372,026 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.0% of the industry book) .
All Filings in ZTS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $782,914 | 10,895 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,058,806 | 8,957 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $878,852 | 6,985 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,182,265 | 8,080 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,430,997 | 9,176 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,511,816 | 9,182 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,532,682 | 9,407 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,870,958 | 9,576 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,651,947 | 9,529 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,325,083 | 7,831 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,492,511 | 7,562 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,382,271 | 7,945 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,578,649 | 9,167 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,423,228 | 8,551 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $947,006 | 6,462 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||